Ex vivo culture, proliferation and expansion of intestinal epithelium
View Patent ↗Methods are provided for long term culture of mammalian intestinal cells. Cultures are initiated with fragments of mammalian intestinal tissue, which are then maintained embedded in a gel substrate that provides an air-liquid interface. Intestinal epithelium in cultures of the invention can be continuously grown for extended periods of time. Mammalian intestinal cells cultured by the methods of the invention recapitulate features of intestinal growth in vivo.
1. A long term culture system of mammalian intestinal cells, wherein said culture provides for multilineage differentiation that maintains (a) the three-dimensional structure of intestinal epithelium and (b) differentiation markers characteristic of intestinal absorptive enterocytes, goblet cells and/or enteroendocrine cells, in which intestinal cells grow, differentiate and are viable for more than 3 months and up to 350 days in culture, comprising intestinal tissue cultured in a gel with an air-liquid interface,
wherein the culture system is initiated by:
mixing fragments of intestinal tissue with a gel solution,
pouring the gel solution containing the fragments of intestinal tissue over a layer of gel substrate formed in a transwell container with a lower semi-permeable support;
placing the transwell in an outer dish comprising culture medium, wherein the level of the culture medium is maintained such that the gel containing the tissue fragments is not submerged in the culture medium;
wherein the long term culture system recapitulates features of intestinal growth in culture comprising cellular ultrastructure, presence of enterocytes, goblet and enteroendocrine cells, and Wnt-dependent proliferation.
2. The method of claim 1 , wherein the fragments of intestinal tissue are neonatal, juvenile or adult.
3. The long term culture of claim 1 , wherein said culture comprises exogenous R-spondin, and wherein the growth of intestinal cells is increased relative to cells in a culture in which R-spondin is absent.
4. The long term culture of claim 1 , wherein the mammalian intestinal cells are experimentally modified prior to or during culture.
5. The in vitro culture of claim 1 , wherein the cells are modified by introduction of a pathogen.
6. The in vitro culture of claim 1 , wherein the cells are modified by introduction of a genetic agent.